CARCINOMA, NEUROENDOCRINE

Clinical trials for CARCINOMA, NEUROENDOCRINE explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear

Sign up with your email to follow new studies for CARCINOMA, NEUROENDOCRINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Promising new combo aims to extend life in rare, Tough-to-Treat cancer

Disease control Not yet recruiting

This study tests whether adding two immunotherapy drugs (zimberelimab and domvanalimab) to standard chemotherapy (FOLFIRI) helps people with a rare, fast-growing neuroendocrine cancer live longer. About 122 adults whose cancer has worsened after first treatment will take part. Th…

Matched conditions: CARCINOMA, NEUROENDOCRINE

Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

CARCINOMA, NEUROENDOCRINE

Get alerted when new CARCINOMA, NEUROENDOCRINE trials appear

Promising new combo aims to extend life in rare, Tough-to-Treat cancer